Dec 2

Sunday

09:00

Registration and Refreshments

The exhibition will open at 09:00 and close at 17:45

10:00

Official Opening (Hall 1)

Mrs Claire L Severgnini, Chief Executive, National Osteoporosis Society

10:30

IS1 -The role of exercise on reducing fragility fractures            (Hall 1)

Dr Lora Giangregorio

11:00

Exercise and bone (Hall 1)

IP1 - How does exercise affect bone? Dr Gabriel Galea

IP2 - Can exercise prevent fractures? The prevention of falls injury trial (PreFIT) Dr Julie Bruce 

IP3 - Physiotherapy after a vertebral fracture – what works and what’s safe? Prof. Karen Barker

IP4 - NOS consensus statement on physical activity and exercise with osteoporosis Prof. Dawn Skelton 

12:15

Lunch, exhibition, Innovation Theatre, poster viewing and meet the speaker session

12.15 - 12.45: Innovation Theatre - California Prunes Europe - 'Supporting your supporting structure: Nutritional strategies to live strong' - Ms Leslie J. Bonci

12.50 - 13.20: Meet the Speaker Session - Dr Lora Giangregorio on 'The role of exercise on reducing fragility fractures'. 

Poster viewing - Treatment and monitoring/Nutrition, lifestyle and physical activity (P1-P29)

13:45

Integrated care pathways - optimizing treatment delivered in primary care (Hall 1)

IP5 - Right patient, right treatment, right time Prof. Tim Briggs CBE

IP6 - Empowering the non-specialist Dr Nicky Peel

IP7 - Empowering the patient Dr Shane Clark & Dr Stuart Eastman     

15:00

Refreshments (Hall 3)

15:15

Parallel Sessions 

IS2 - UK Biobank: an internationally unique resource for musculoskeletal research Prof. Nicholas Harvey (Hall 1)

IS3 -  What’s the score with vitamins and minerals in bone health?               
Prof. Ailsa Welch (Hall 11a)

15:45

Oral Abstracts 

Hall 1 

O1 Falls and fractures and their risk factors in UK south Asians aged 40-69 years: novel data from the UK biobank cohort – Dr Andrea Darling

O2 Low bone mineral density and risk of falls are increased among individuals with rheumatoid arthritis: findings from UK biobank – Dr Michael Clynes

O3 - The impact of social deprivation on health outcomes following hospital admission for hip fracture in England – Dr Arti Bhimjiyani 

 

Hall 11a 

O4 The association between serum concentrations of vitamin K1 (phylloquinone) and fracture risk in post-menopausal osteoporosis - Dr A Moore

O5 - Urine C-terminal telopeptide of type I collagen (CTX) in pregnancy is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the MAVIDOS trial – Dr Elizabeth Curtis

O6 - Bone health benefits of sunlight exposure and vitamin D supplementation: results from parallel randomized trials in opposite latitudes – Miss Marcela Mendes 

16:25

Parallel Workshops

S1- Exercise and osteoporosis- putting new principles into practice             
Prof. Dawn Skelton (Hall 11a)

S2- Fracture risk assessment case studies
Prof. Eugene McCloskey (Hall 7b)

S3- Osteoporosis treatment and dental care Prof. David Reid (Hall 7a)

S4- Renal case studies Prof. Mike Stone (Hall 6a)

S5- Bone Turnover Markers to monitor osteoporosis treatment
Dr Jennie Walsh & Prof. Richard Eastell (Exec 1)

S6- Empowering the patient: how to effectively communicate risk
Dr Zoe Paskins & Dr Nuttan Tanna (Exec 2)

S7- Clinical Interpretation of DXA
Dr Claire Higham & Dr Tehseen Ahmed (Hall 11b)

S8- Osteoporosis, frailty and sarcopenia in the community- nutritional interventions Dr Kate Ward (Hall 6b)

17:25

Break 

17:45

Satellite symposium (Hall 1)

UCB Pharma Ltd 

Strengthening our approach in fragility fractures: let's talk about risk

19:00

End of Day One 

Dec 3

Monday

07:30

Registration Open 

The exhibition will open at 08:00 and close at 17:30 (Hall 3)

08:00

Satellite symposium (Hall 1)

Consilient Health 

09:05

Parallel Sessions 

IS4 - Impact of an aging immune system on frailty and bone health
Prof. Janet Lord (Hall 1)

IS5 - Bone Densitometry - Empowering the AHP
Dr Nicola Crabtree (Hall 11a)

 

09:35

Oral Abstracts 

Hall 1 

O7 Relationships between the hypothalamic-pituitary-axis and bone microarchitecture – Dr Nicholas Fuggle

O8 Fat mass and lean mass are predictive of bone microarchitecture in the global longitudinal study of osteoporosis in women (glow) study – Dr Kate Ward

O9 - Response to alendronate treatment and discontinuation in the femoral neck – Dr Diane Powell

Hall 11a

O10 - Impact of a radiology department email alert system on vertebral fracture case finding – Dr Helena Robinson

O11 - How different loading sports affect bone development during adolescence and how to improve it? The Pro-Bone study findings –Dr Dimitris Vlachopoulos

O12 - Investment in physiotherapy after hip fracture – results of the national ‘Hip Sprint’ audit in 2017 – Dr Anthony Johansen

10:05

Refreshments (Hall 3)

10:20

Vertebral Fractures (Hall 1)

IP8 - Identifying vertebral fractures that present clinically Dr Emma Clark

IP9 - Identifying vertebral fractures that do not present clinically
Dr Clare Groves                                      

IP10 - Management approach of the patient with vertebral fractures
Prof. Opinder Sahota

11:45

Parallel Workshops

M1- Case Studies on vertebral fracture management Dr Terence Ong (Hall 6a)

M2- Optimising DXA: A focus on quality assurance
Mrs Jill Griffin & Dr Karen Knapp (Hall 7b)

M3- Medications affecting bone health Dr Stephen Gallacher (Hall 7a)

M4- FLS: How to deliver quality improvement Dr Kassim Javaid (Exec 1)

M5- Managing osteoporosis in patients with limited life-expectancy
Dr David Armstrong (Exec 2)

M6- HIV and Bone Dr Karen Walker-Bone (Hall 6b)

M7- Osteoporosis in the very elderly Dr Madhavi Vindlacheruvu (Hall 11b)

M8- Osteoporosis in young adults Dr Richard Keen (Hall 11a)

12:45

Lunch, exhibition, poster viewing and meet the speaker session 

12.45-13.15: Meet the Speaker Session - Professor Ailsa Welch on 'what's the score with vitamins and minerals in bone health?'

Poster Viewing - Epidemiology and pathophysiology/ Miscellaneous (P30-P60)

13.25-13.55: Innovation Theatre - Eli Lilly

14:00

Fragility fractures that are not due to osteoporosis (Hall 1)

IP11 - Brittle Bones Dr Kassim Javaid                                       

IP12 - Soft Bones Dr Fadil Hannan

15:00

Oral Abstracts (Hall 1)

O13 - Gap Analyses of Fracture Liaison Services in the UK: 2015-2018 – Mr Will Carr

O14Oral bisphosphonates and chronic kidney disease: progression and safetyMiss Danielle Robinson 

O15Treatment recommendations after fragility fracture: results of the world’s first national patient-level clinical audit of fracture liaison services – Dr Kassim Javaid

O16 Early biochemical monitoring of osteoporosis treatment in primary care improves 5-year outcomes – Mr Ian Baxter

O17 – Outcomes in patients with poor bone turnover response to teriparatide – Dr D Narayanan

O18 - Oral bisphosphonate prescription in primary care: a baseline audit of practice – Dr JJ Edwards

16:00

IS6 - What DXA doesn’t tell us (Hall 1)

Dr Ken Poole

19:00

Conference Dinner & Awards 

Hall 4 - Birmingham ICC

Dec 4

Tuesday

08:00

Registration open 

The exhibition will open at 08:00 and close at 14:45 (Hall 3)

08:00

Satellite symposium (Hall 1)

09:05

IS7 - Strategies at each stage of life for prevention of fragility fracture (Hall 1)

Prof. Cyrus Cooper OBE

09:35

Oral Abstracts (Hall 1) 

O19 – Age at onset of walking in infancy is associated with hip and spine shape in early old age – Dr Alex Ireland

O20 – Systematic screening using FRAX leads to increased use of, and adherence to, anti-osteoporosis medications: The UK SCOOP Trial – Dr Camille Parsons

O21 - Women identified at high risk of hip fracture based on FRAX are responsive to appropriate osteoporosis management: analysis from the SCOOP study of population screening – Prof. Eugene McCloskey

10:05

Refreshments (Hall 3)

10:20

IS8 - Atypical Femoral Fractures: What can we learn from epidemiology? (Hall 1)

Prof. Angela Cheung

10:50

Orthopaedic interface (Hall 1)

IP13 - Fracture healing Prof. Mark Wilkinson

IP14 - Insufficiency and stress fractures Prof. Mike Stone

IP15 - Lessons learnt from 10 years of NHFD Dr Anthony Johansen

IP16 - Orthopaedic approach to atypical fracture management Dr Andrew Gray

12:05

Lunch, exhibition, poster viewing and meet the speaker session

12.50 - 13.20: Meet the Speaker Session - Professor Angela Cheung for a discussion on 'Atypical Femoral Fractures: What can we learn from epidemiology'

Poster Viewing - Bone densitometry and fracture risk assessment/Secondary fracture prevention (P61-P94)

13:30

Parallel Workshops

T1- Exercise and osteoporosis- putting new principles into practice
Prof. Dawn Skelton (Hall 7a)

T2- Fracture risk assessment case studies Prof. Eugene McCloskey (Exec 2)

T3- Case Studies on vertebral fracture management Dr Terence Ong (Hall 6a)

T4- Bone Turnover Markers to monitor osteoporosis treatment
Dr Jennie Walsh (Hall 7b)

T5- Medications affecting bone health Dr Stephen Gallacher (Hall 11b)

T6- Osteoporosis, frailty and sarcopenia in the community- nutritional interventions Dr Kate Ward (Hall 6b)

T7- Clinical Interpretation of DXA
Dr Claire Higham & Dr Tehseen Ahmed (Hall 11a)

T8- Renal case studies Prof. Mike Stone (Exec 1)

14:30

Refreshments (Hall 3)

14:45

IS9 - Debate – ‘This house believes that HRT should be first-line treatment for postmenopausal osteoporosis in women under 60’ (Hall 1)

Prof. Juliet Compston OBE & Dr David Armstrong

15:45

IS10 - Innovation and discovery - the future of bone health (Hall 1)

Dr René Rizzoli

16:15

IS11 - Linda Edwards Award Lecture - Tools to Guide Decisions Regarding Long-Term Treatment of Osteoporosis (Hall 1)

Professor Richard Eastell

16:45

The Young Scientist Award Lecture (Hall 1)

17:00

Closing remarks (Hall 1)

Dr Nicola Peel, Conference Chair 

17:15

Conference Closes